L51.2 Toxic epidermal necrolysis [Lyell]

Name of the Condition

• Toxic epidermal necrolysis [Lyell]

Summary

Toxic epidermal necrolysis (TEN) is a severe, life-threatening skin condition characterized by widespread epidermal detachment and mucous membrane involvement. It is a rare but serious adverse reaction, often requiring immediate medical intervention.

Causes

Most commonly triggered by medications, particularly anticonvulsants, antibiotics, and nonsteroidal anti-inflammatory drugs (NSAIDs). Infections, such as Mycoplasma pneumoniae, can also be a cause.

Risk Factors

• Recent use of certain medications, especially new or multiple drugs.
• Genetic predisposition (e.g., specific HLA alleles).
• Pre-existing infections, such as herpes simplex or Mycoplasma.

Symptoms

• Rapid onset of painful, red or purplish skin rash.
• Widespread blistering and skin peeling, often affecting over 30% of body surface area.
• Mucous membrane involvement (eyes, mouth, genitalia) with pain or ulceration.
• Fever and general malaise.

Diagnosis

Primarily based on clinical presentation, including widespread skin detachment and mucous membrane involvement. A skin biopsy may be performed to confirm diagnosis and rule out other conditions like Stevens-Johnson syndrome.

Treatment Options

• Immediate discontinuation of the suspected causative medication.
• Hospitalization in a burn unit or intensive care setting for supportive care.
• Fluid and electrolyte management, pain control, and infection prevention.
• Skin care with dressings and topical agents to promote healing.

Prognosis and Follow-Up

Prognosis depends on the extent of skin detachment and comorbidities. Mortality can be significant, especially with extensive involvement. Long-term follow-up is necessary to monitor for complications and recurrence.

Complications

• Sepsis due to skin barrier disruption.
• Eye complications (e.g., dryness, scarring, vision loss).
• Respiratory or gastrointestinal involvement.
• Psychological impact from disfigurement or trauma.

Lifestyle & Prevention

• Avoid known triggers, particularly medications associated with TEN.
• Inform healthcare providers of any history of adverse drug reactions.
• Promptly report new rashes or symptoms after starting a new medication.

When to Seek Professional Help

Seek immediate medical attention if you experience a widespread rash, blistering, or mucous membrane symptoms, especially after starting a new medication.

Tips for Medical Coders

Document the extent of skin detachment, mucous membrane involvement, and causative factors (e.g., medication or infection) to support accurate coding. Ensure clinical correlation with the severity and progression of the condition.